Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dolby Laboratories (DLB) Restructuring Costs (2016 - 2025)

Dolby Laboratories' Restructuring Costs history spans 17 years, with the latest figure at $10.5 million for Q4 2025.

  • For Q4 2025, Restructuring Costs rose 100.65% year-over-year to $10.5 million; the TTM value through Dec 2025 reached $20.3 million, up 77.71%, while the annual FY2025 figure was $15.0 million, 135.07% up from the prior year.
  • Restructuring Costs reached $10.5 million in Q4 2025 per DLB's latest filing, up from $6.1 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $13.4 million in Q3 2023 to a low of -$2.5 million in Q1 2024.
  • Average Restructuring Costs over 5 years is $3.7 million, with a median of $4.1 million recorded in 2024.
  • Peak YoY movement for Restructuring Costs: soared 3132.79% in 2023, then tumbled 7660.61% in 2024.
  • A 5-year view of Restructuring Costs shows it stood at -$95000.0 in 2021, then crashed by 156.84% to -$244000.0 in 2022, then soared by 3132.79% to $7.4 million in 2023, then dropped by 29.51% to $5.2 million in 2024, then soared by 100.65% to $10.5 million in 2025.
  • Per Business Quant, the three most recent readings for DLB's Restructuring Costs are $10.5 million (Q4 2025), $6.1 million (Q3 2025), and -$547000.0 (Q2 2025).